299 related articles for article (PubMed ID: 32713026)
1. Circulating microRNA-15b-5p as a biomarker for asthma-COPD overlap.
Hirai K; Shirai T; Shimoshikiryo T; Ueda M; Gon Y; Maruoka S; Itoh K
Allergy; 2021 Mar; 76(3):766-774. PubMed ID: 32713026
[TBL] [Abstract][Full Text] [Related]
2. Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.
Shirai T; Hirai K; Gon Y; Maruoka S; Mizumura K; Hikichi M; Holweg C; Itoh K; Inoue H; Hashimoto S
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):134-145.e1. PubMed ID: 29981861
[TBL] [Abstract][Full Text] [Related]
3. The Plasma Levels of hsa-miR-19b-3p, hsa-miR-125b-5p, and hsamiR- 320c in Patients with Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS).
Bersimbaev R; Aripova A; Bulgakova O; Kussainova А; Akparova A; Izzotti A
Microrna; 2021; 10(2):130-138. PubMed ID: 34151771
[TBL] [Abstract][Full Text] [Related]
4. Upregulated microRNA-125b-5p in patients with asthma-COPD overlap mediates oxidative stress and late apoptosis via targeting IL6R/TRIAP1 signaling.
Chang YP; Tsai YH; Chen YM; Huang KT; Lee CP; Hsu PY; Chen HC; Lin MC; Chen YC
Respir Res; 2024 Feb; 25(1):64. PubMed ID: 38302925
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilic COPD Patients Display a Distinctive Serum miRNA Profile From Asthma and Non-eosinophilic COPD.
Asensio VJ; Tomás A; Iglesias A; de Llano LP; Del Pozo V; Cosío BG;
Arch Bronconeumol (Engl Ed); 2020 Apr; 56(4):234-241. PubMed ID: 31732359
[TBL] [Abstract][Full Text] [Related]
6. Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
Wang J; Lv H; Luo Z; Mou S; Liu J; Liu C; Deng S; Jiang Y; Lin J; Wu C; Liu X; He J; Jiang D
Respir Res; 2018 Mar; 19(1):47. PubMed ID: 29580282
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics-based identification of potential microRNA biomarkers in frequent and non-frequent exacerbators of COPD.
Liu X; Qu J; Xue W; He L; Wang J; Xi X; Liu X; Yin Y; Qu Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():1217-1228. PubMed ID: 29713155
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel circulating miRNAs biomarkers for healthy obese and lean children.
Ma F; Cao D; Liu Z; Li Y; Ouyang S; Wu J
BMC Endocr Disord; 2023 Oct; 23(1):238. PubMed ID: 37904219
[TBL] [Abstract][Full Text] [Related]
9. Peripheral leukocyte microRNAs as novel biomarkers for COPD.
Wang R; Xu J; Liu H; Zhao Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():1101-1112. PubMed ID: 28435243
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype.
Lacedonia D; Palladino GP; Foschino-Barbaro MP; Scioscia G; Carpagnano GE
Int J Chron Obstruct Pulmon Dis; 2017; 12():1811-1817. PubMed ID: 28694694
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).
Ghosh N; Choudhury P; Kaushik SR; Arya R; Nanda R; Bhattacharyya P; Roychowdhury S; Banerjee R; Chaudhury K
Respir Res; 2020 May; 21(1):126. PubMed ID: 32448302
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease.
Xie S; Niu W; Xu F; Wang Y; Hu S; Niu C
Int J Neurosci; 2022 Jul; 132(7):673-688. PubMed ID: 33045885
[TBL] [Abstract][Full Text] [Related]
13. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
14. Association of recurrent venous thromboembolism and circulating microRNAs.
Wang X; Sundquist K; Svensson PJ; Rastkhani H; Palmér K; Memon AA; Sundquist J; Zöller B
Clin Epigenetics; 2019 Feb; 11(1):28. PubMed ID: 30760335
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
[TBL] [Abstract][Full Text] [Related]
16. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
17. Circulating miRNAs act as potential biomarkers for asthma.
Hu G; Du Y; Xie M; Chen R; Shi F
Front Immunol; 2023; 14():1296177. PubMed ID: 38173723
[TBL] [Abstract][Full Text] [Related]
18. Possible relation between expression of circulating microRNA and plasma cytokine levels in cases of pulmonary tuberculosis.
Ulger M; Serin MS; Tezcan Ulger S; Aslan G; Ilvan A; Tiftik EN; Emekdas G
J Infect Dev Ctries; 2022 Jul; 16(7):1166-1173. PubMed ID: 35905021
[TBL] [Abstract][Full Text] [Related]
19. Plasma miR-150-5p as a Biomarker for Chronic Obstructive Pulmonary Disease.
Ding Y; Tang S; Zhou Z; Wei H; Yang W
Int J Chron Obstruct Pulmon Dis; 2023; 18():399-406. PubMed ID: 36993790
[TBL] [Abstract][Full Text] [Related]
20. Plasma microRNA expression levels in HIV-1-positive patients receiving antiretroviral therapy.
Marquez-Pedroza J; Cárdenas-Bedoya J; Morán-Moguel MC; Escoto-Delgadillo M; Torres-Mendoza BM; Pérez-Ríos AM; González-Enriquez GV; Vázquez-Valls E
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32319513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
